Relmada Therapeutics
RLMD
#7832
Rank
HK$2.56 B
Marketcap
HK$35.02
Share price
1.81%
Change (1 day)
858.39%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: HK$2.56 Billion

As of December 2025 Relmada Therapeutics has a market cap of HK$2.56 Billion. This makes Relmada Therapeutics the world's 7832th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$2.56 B2762.2%
2024HK$89.72 M-90.78%
2023HK$0.97 B18.58%
2022HK$0.82 B-83.16%
2021HK$4.87 B20.02%
2020HK$4.06 B-7.53%
2019HK$4.39 B1538.21%
2018HK$0.26 B264.67%
2017HK$73.5 M-27.74%
2016HK$0.10 B-56.25%
2015HK$0.23 B-81.99%
2014HK$1.29 B

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Relmada Therapeutics was reported to be:

HK$2.52 Billion
by Nasdaq info icon info icon
HK$2.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Taro Pharmaceutical
TARO
HK$12.56 B 389.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cytokinetics
CYTK
HK$57.20 B 2,127.81%๐Ÿ‡บ๐Ÿ‡ธ USA